Medical giant Johnson & Johnson (JNJ) early Tuesday delivered strong quarterly results, led by its hepatitis C drug Olysio. But J&J stock slid nearly 1.5% in morning trading, as the company does not expect the growth rate to continue. J&J’s earnings, excluding one-time items, rose 12% over the year-earlier quarter to $1.66 a share, beating analysts’ consensus by 11 cents. Sales rose 9% to $19.5 billion, about $500 million above estimates. The
When Epam Systems warned investors that Russia’s incursion into Ukraine could hurt its business, things looked bad for the company. Shares of the information-technology services provider plunged more than 27% on March 3, the day Epam issued its warning in a public filing, though the stock did recover 16% the next day. Epam Systems (EPAM) stock has since slipped but remains up 11% for 2014. The stock has been lifted by better-than-expected Q1
Time Warner is facing the 21st-century media corporation’s ultimate challenge: remaining relevant in a digital culture. This task is exacerbated for Time Warner (TWX), whose assets include cable TV news giant CNN, Warner Bros. films and the Home Box Office entertainment channel. That’s because it is so closely identified with the classic 20th-century media industry, despite its ill-fated and ill-timed merger with AOL (AOL), which it has since spun